These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19998214)

  • 1. [Detection of a neuroendocrine differentiated cystic pancreatic lesion by gallium-68-DOTATOC-PET/CT with inconclusive MRI, CT and ultrasound diagnosis].
    Fröling V; Denecke T; Pöllinger A; Schreiter NF
    Rofo; 2010 Feb; 182(2):175-7. PubMed ID: 19998214
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
    Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
    Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of pancreatic neuroendocrine tumors (PNET) using semi-quantitative [68Ga]DOTATOC PET in combination with multiphase contrast-enhanced CT.
    Froeling V; Röttgen R; Collettini F; Rothe J; Hamm B; Brenner W; Schreiter N
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):310-8. PubMed ID: 25265251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non invasive methods in competition for EUS (US, CE-US, CT, MRI and PET/CT): the radiologist point of view].
    Martina MC; Cassinis MC; Tappero C; Gandini G
    Minerva Med; 2007 Aug; 98(4):343-50. PubMed ID: 17921948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cystic tumors of the pancreas].
    Zanow J; Gellert K; Benhidjeb T; Müller JM
    Chirurg; 1996 Jul; 67(7):719-24. PubMed ID: 8776544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of (68)Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours.
    Kumar R; Sharma P; Garg P; Karunanithi S; Naswa N; Sharma R; Thulkar S; Lata S; Malhotra A
    Eur Radiol; 2011 Nov; 21(11):2408-16. PubMed ID: 21750886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI.
    Giesel FL; Kratochwil C; Mehndiratta A; Wulfert S; Moltz JH; Zechmann CM; Kauczor HU; Haberkorn U; Ley S
    Eur J Radiol; 2012 Oct; 81(10):2820-5. PubMed ID: 22236704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonfunctioning cystic neuroendocrine neoplasms of the pancreas.
    Schwartz RW; Munfakh NA; Zweng TN; Strodel WE; Lee E; Thompson NW
    Surgery; 1994 May; 115(5):645-9. PubMed ID: 8178265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of positive
    Zilli A; Fanetti I; Conte D; Massironi S
    Clin Imaging; 2018; 49():156-158. PubMed ID: 29529451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 68Ga-DOTATOC PET/CT in carcinoids.
    Jindal T; Kumar A; Kumar R; Dutta R
    Pathol Int; 2010 Feb; 60(2):143-4. PubMed ID: 20398201
    [No Abstract]   [Full Text] [Related]  

  • 14. 18F-FDG PET/CT and 68Ga-DOTATOC PET/CT in Diffuse Pancreatic Neuroendocrine Tumor.
    Ji X; Dong A; He Q; Dong H; Zuo C
    Clin Nucl Med; 2020 May; 45(5):e245-e248. PubMed ID: 32049733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to (68)Ga-DOTATOC PET.
    Flechsig P; Zechmann CM; Schreiweis J; Kratochwil C; Rath D; Schwartz LH; Schlemmer HP; Kauczor HU; Haberkorn U; Giesel FL
    Eur J Radiol; 2015 Aug; 84(8):1593-1600. PubMed ID: 25999064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours.
    Schreiter NF; Brenner W; Nogami M; Buchert R; Huppertz A; Pape UF; Prasad V; Hamm B; Maurer MH
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):72-82. PubMed ID: 21927931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should all pancreatic cystic lesions be resected? Cyst-fluid analysis in the differential diagnosis of pancreatic cystic lesions: a meta-analysis.
    Brugge WR
    Gastrointest Endosc; 2005 Sep; 62(3):390-1. PubMed ID: 16111957
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of cystic pancreatic masses.
    Op de Beeck B; Spinhoven M; Corthouts B; de Jongh K; Salgado R; Parizel P
    JBR-BTR; 2007; 90(6):482-6. PubMed ID: 18376760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypokalemic rhabdomyolysis without watery diarrhea: an unexpected presentation of a pancreatic neuro-endocrine tumor.
    Rossi V; Saibeni S; Sinigaglia L; Peracchi M; Parafioriti A; Vecchi M
    Am J Gastroenterol; 2006 Mar; 101(3):669-72. PubMed ID: 16464230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of non-functioning pancreatic islet cell tumors.
    Kouvaraki MA; Solorzano CC; Shapiro SE; Yao JC; Perrier ND; Lee JE; Evans DB
    J Surg Oncol; 2005 Mar; 89(3):170-85. PubMed ID: 15719379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.